Lisa Christiansson
Overview
Explore the profile of Lisa Christiansson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lof L, Arngarden L, Olsson-Stromberg U, Siart B, Jansson M, Dahlin J, et al.
Sci Rep
. 2017 Apr;
7(1):623.
PMID: 28377570
Chronic myeloid leukemia (CML) is characterized in the majority of cases by a t(9;22)(q34;q11) translocation, also called the Philadelphia chromosome, giving rise to the BCR-ABL1 fusion protein. Current treatment with...
2.
Soderlund S, Christiansson L, Persson I, Hjorth-Hansen H, Richter J, Simonsson B, et al.
Leuk Res
. 2016 Oct;
50:95-103.
PMID: 27710869
Background And Aims: The simultaneous measurement of many proteins is now possible using multiplex assays. In this pilot study we investigated a total of 124 proteins in plasma from chronic...
3.
Christiansson L, Soderlund S, Mangsbo S, Hjorth-Hansen H, Hoglund M, Markevarn B, et al.
Mol Cancer Ther
. 2015 Mar;
14(5):1181-91.
PMID: 25761894
Immune escape mechanisms promote tumor progression and are hurdles of cancer immunotherapy. Removing immunosuppressive cells before treatment can enhance efficacy. Tyrosine kinase inhibitors (TKI) may be of interest to combine...
4.
Christiansson L, Soderlund S, Svensson E, Mustjoki S, Bengtsson M, Simonsson B, et al.
PLoS One
. 2013 Feb;
8(1):e55818.
PMID: 23383287
Immunotherapy (eg interferon α) in combination with tyrosine kinase inhibitors is currently in clinical trials for treatment of chronic myeloid leukemia (CML). Cancer patients commonly have problems with so called...